Business Context and Reporting Period
Company: iSpecimen Inc. (ISPC)
Filing Type: Form 8-K (Current Report)
Date of Report: July 23, 2025
Reporting Period: Events occurring on July 23, 2025, with the offering closing on July 25, 2025.
Context: The Company, an emerging growth company incorporated in Delaware, entered into a material definitive agreement to conduct an underwritten public offering of common stock and pre-funded warrants.
Key Financial Metrics
This filing reports on a capital raise event rather than periodic operating results. Specific metrics include:
- Gross Proceeds: Approximately $4,000,000.
- Net Proceeds: Approximately $3,528,902 (after underwriting discounts, commissions, and estimated offering expenses).
- Securities Issued: 5,714,283 total securities consisting of:
- 1,482,644 shares of Common Stock.
- 4,231,639 Pre-Funded Warrants (exercise price $0.0001 per share).
- Offering Price: $0.70 per share (or $0.6999 per Pre-Funded Warrant).
- Liquidity Impact: Immediate increase in cash reserves via net proceeds.
Note: The filing text does not provide clear values for revenue, profit, operating cash flow, margins, or existing debt levels.
Material Changes
The primary material change is the execution of an underwriting agreement with WestPark Capital, Inc. and the subsequent closing of the offering. This transaction significantly alters the Company's capital structure by increasing the number of outstanding shares and pre-funded warrants, and increases available cash by approximately $3.53 million.
Guidance, Outlook, and Use of Proceeds
Use of Proceeds: Management intends to allocate the net proceeds as follows:
- $1,500,000: Marketing and advertising services under a Consulting Agreement with IR Agency LLC.
- $1,000,000: Initial milestone payment under a Software Purchase and Services Agreement with Sales Stack Solutions Corp.
- Remaining Proceeds: Working capital and general corporate purposes.
Management Commentary: The Company issued press releases on July 23 and July 25, 2025, announcing the pricing and closing of the offering, respectively. No specific forward-looking financial guidance or revenue projections were included in this text.
Investor Verification Checklist
- Verify the final number of shares outstanding post-offering to assess dilution impact.
- Review the full text of the Consulting Agreement with IR Agency LLC and the Software Purchase Agreement with Sales Stack Solutions Corp. (Exhibits 10.2 and 10.3) to understand service deliverables and payment terms.
- Confirm the exercise terms and blackout periods for the Pre-Funded Warrants, specifically the 4.99% beneficial ownership limitation.
- Monitor subsequent filings for the actual deployment of the $2.5 million allocated to specific third-party vendors versus general working capital.